{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02104440",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CSM/CIT"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "2013-000534-35",
            "SecondaryIdType": "EudraCT Number"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "Red de Terapia Celular",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2017",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 2013"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 2017",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "March 2017",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "January 22, 2014",
      "StudyFirstSubmitQCDate": "April 3, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 4, 2014",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 29, 2017",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 30, 2017",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Red de Terapia Celular",
        "LeadSponsorClass": "INDUSTRY"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "University of Navarrra Hospital (Clinica Universitaria)",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Hospitales Universitarios Virgen del Rocío",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Spanish National Health System",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to evaluate the safety and efficacy of the sequential infusion of allogeneic mesenchymal stem cells (MSC), expanded \"in vitro\" with platelet lysate without addition of animal products in the treatment of patients undergoing allo-HSCT who developed one or more cytopenias."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Cytopenia"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Cytopenia"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "15",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Patients with cytopenia after allo-HSCT",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patients with cytopenia after allo-HSCT",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Sequential infusion of allogeneic mesenchymal stem cells expanded \"in vitro\""
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Sequential infusion of allogeneic mesenchymal stem cells expanded \"in vitro\"",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Patients with cytopenia after allo-HSCT"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Adverse effects at the time of infusion and infections after infusion of MSC",
            "PrimaryOutcomeDescription": "All the adverse effects that may arise and possible toxicities (WHO grade) after infusion of the cells were collected.",
            "PrimaryOutcomeTimeFrame": "During the period of infusion of the cells into the patient (an average of one hour)"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Mesenchymal cell efficiency in recovering cytopenia",
            "SecondaryOutcomeDescription": "The efficiency is measured by the recovery of cytopenia after administration of MSC (depending on the original cytopenia) and may be of two types:\n\nComplete response:\n\nHb> 10 g / dL\nNeutrophils> 1500 Million / L\nPlatelets> 100.000 Million / L\nMaintained at least 7 days\n\nPartial response:\n\nHb> 8 and <10 g / dL\nNeutrophils> 1000 and <1500 Million / L\nPlatelets> 50000 and <100.000 Million / L\nMaintained at least 7 days",
            "SecondaryOutcomeTimeFrame": "Monitoring will be from the last infusion of MSCs to the patient until 90 days after the last administration"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with hematologic malignancies who have been subjected to allo-HSCT and that are diagnosed with one or more peripheral cytopenias with complete chimerism in bone marrow (determined by molecular-STR-studies). They may include:\n\nPatients who have received as a source of cells MO or SP\nPatients who have received cells from a related donor or unrelated HLA-matched\nPatients transplanted with myeloablative or non-myeloablative conditioning\nAdequate cardiac function assessed from a clinical point of view by the researcher, with no history of ischemic heart disease (angina or myocardial infarction) in the previous 6 months.\nAdequate pulmonary function assessed clinically without evidence of severe obstructive or restrictive lung disease.\nPatients between 18 and 70 years\nSigned informed consent\n\nExclusion Criteria:\n\nPatients whose haemopathy has not been controlled by the transplantation or is in progress at the time of treatment.\nPatients who do not have complete chimerism in bone marrow (performed within 28 days prior to baseline by molecular study -STR-).\nPatients with thrombotic microangiopathy.\nPatients with post-transplant cytopenias with toxic origin in relation to antiviral treatment (eg ganciclovir, valganciclovir) without concomitant graft against host disease.\nPatients with bacterial, viral or fungal infection that is not being controlled with proper treatment.\nPatients with a history of ischemic heart disease (angina or myocardial infarction) in the previous 6 months, and those considered by the investigator does not have adequate cardiac function, evaluated from a clinical point of view.\nPatients with poor lung function, evaluated clinically, according to the researcher.\nPatients who, in the opinion of the investigator, are not on a good position to tolerate treatment.\nPatients who do not have the required donor.\nWomen pregnant or at risk of pregnancy by contraceptive measures inadequate.\nPatients <18 or > 70 years.\nPatients who did not sign the informed consent.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Fermín Sánchez-Guijo Martín, Ph.D",
            "OverallOfficialAffiliation": "University Clinical Hospital of Salamanca",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "José Rifón Roca, Ph.D",
            "OverallOfficialAffiliation": "University of Navarrra Hospital (Clinica Universitaria)",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "José A Pérez Simón, Ph.D",
            "OverallOfficialAffiliation": "Hospital Virgen del Rocío",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "University Clinical Hospital of Salamanca",
            "LocationCity": "Salamanca",
            "LocationState": "Salamanca/Castilla León",
            "LocationZip": "37007",
            "LocationCountry": "Spain"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000000740",
            "ConditionMeshTerm": "Anemia"
          },
          {
            "ConditionMeshId": "D000007970",
            "ConditionMeshTerm": "Leukopenia"
          },
          {
            "ConditionMeshId": "D000013921",
            "ConditionMeshTerm": "Thrombocytopenia"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000006402",
            "ConditionAncestorTerm": "Hematologic Diseases"
          },
          {
            "ConditionAncestorId": "D000007960",
            "ConditionAncestorTerm": "Leukocyte Disorders"
          },
          {
            "ConditionAncestorId": "D000001791",
            "ConditionAncestorTerm": "Blood Platelet Disorders"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M3222",
            "ConditionBrowseLeafName": "Anemia",
            "ConditionBrowseLeafAsFound": "Cytopenia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10125",
            "ConditionBrowseLeafName": "Leukopenia",
            "ConditionBrowseLeafAsFound": "Cytopenia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M15832",
            "ConditionBrowseLeafName": "Thrombocytopenia",
            "ConditionBrowseLeafAsFound": "Cytopenia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8642",
            "ConditionBrowseLeafName": "Hematologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10115",
            "ConditionBrowseLeafName": "Leukocyte Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4224",
            "ConditionBrowseLeafName": "Blood Platelet Disorders",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC15",
            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}